General Information of the Compound
| Compound ID |
CP0952259
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
Cyclo-4-amino-5-(dibenzo[b,d]furan-4-yl)-7-beta-D-ribofuranosyl-7H-pyrrolo[2,3-d]pyrimidine5'-O-phosphate(3'->5')Guanosine5'-O-phosphate(2'->5')
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C33H31N9O14P2
|
||||||||||||||||||
| Molecular Weight |
839.608
|
||||||||||||||||||
| Canonical SMILES |
Nc1nc2c(ncn2[C@@H]2O[C@@H]3COP(=O)(O)O[C@H]4[C@@H](O)[C@H](n5cc(-c6cccc7c6oc6ccccc67)c6c(N)ncnc65)O[C@@H]4COP(=O)(O)O[C@@H]2[C@@H]3O)c(=O)[nH]1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C33H31N9O14P2/c34-27-20-16(15-6-3-5-14-13-4-1-2-7-17(13)52-24(14)15)8-41(28(20)37-11-36-27)31-23(44)25-19(54-31)10-51-58(48,49)56-26-22(43)18(9-50-57(46,47)55-25)53-32(26)42-12-38-21-29(42)39-33(35)40-30(21)45/h1-8,11-12,18-19,22-23,25-26,31-32,43-44H,9-10H2,(H,46,47)(H,48,49)(H2,34,36,37)(H3,35,39,40,45)/t18-,19-,22-,23-,25-,26-,31-,32-/m1/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
JCSILUXBZPSGBQ-ZLUZWUJJSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound